Cross Shawn insider trades
Cross Shawn has filed 26 Form 4s with the SEC that we hold, for AMTI (CEO & Chair of the Board, Director), Pacira BioSciences, Inc. (PCRX) (Chief Financial Officer) and CYTH (Director). Across all of them we count 0 purchases worth $0 and 22 sales worth $1.9M reported on Form 4. In the last 12 months: 0 purchases ($0) and 7 sales ($1.5M). The largest single trade was a sale of 15,896 shares of Pacira BioSciences, Inc. worth $397.9K, dated 2025-12-09. The first filing on our record is dated 2021-08-23 and the latest 2026-04-24.
AMTI
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2021-08-19 | S, sale reported on Form 4 | 300 | $9.0K | 2021-08-23 | SEC |
| 2021-08-23 | S, sale reported on Form 4 | 9,700 | $292.2K | 2021-08-23 | SEC |
| 2022-06-01 | S, sale reported on Form 4 | 1,767 | $5.2K | 2022-06-03 | SEC |
| 2022-06-02 | S, sale reported on Form 4 | 2,166 | $6.6K | 2022-06-03 | SEC |
| 2022-09-01 | S, sale reported on Form 4 | 416 | $591 | 2022-09-06 | SEC |
| 2022-09-01 | S, sale reported on Form 4 | 468 | $665 | 2022-09-06 | SEC |
| 2022-12-02 | S, sale reported on Form 4 | 3,893 | $4.1K | 2022-12-06 | SEC |
| 2023-03-01 | S, sale reported on Form 4 | 934 | $467 | 2023-03-03 | SEC |
| 2023-06-02 | S, sale reported on Form 4 | 3,293 | $790 | 2023-10-04 | SEC |
| 2023-06-02 | S, sale reported on Form 4 | 536 | $129 | 2023-10-04 | SEC |
| 2023-06-02 | S, sale reported on Form 4 | 477 | $114 | 2023-10-04 | SEC |
| 2023-09-05 | S, sale reported on Form 4 | 1,253 | $263 | 2023-10-04 | SEC |
| 2023-09-29 | S, sale reported on Form 4 | 193,960 | $31.0K | 2023-10-02 | SEC |
| 2023-11-15 | S, sale reported on Form 4 | 90,447 | $14.5K | 2023-11-16 | SEC |
| 2023-11-22 | S, sale reported on Form 4 | 110,802 | $17.7K | 2023-11-24 | SEC |
Pacira BioSciences, Inc. (PCRX)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2025-11-10 | S, sale reported on Form 4 | 12,060 | $266.4K | 2025-11-13 | SEC |
| 2025-12-09 | S, sale reported on Form 4 | 15,896 | $397.9K | 2025-12-11 | SEC |
| 2025-12-10 | S, sale reported on Form 4 | 9,104 | $228.9K | 2025-12-11 | SEC |
| 2026-04-20 | S, sale reported on Form 4 | 7,714 | $193.9K | 2026-04-22 | SEC |
| 2026-04-21 | S, sale reported on Form 4 | 2,845 | $71.2K | 2026-04-22 | SEC |
| 2026-04-22 | S, sale reported on Form 4 | 1,500 | $37.5K | 2026-04-22 | SEC |
| 2026-04-23 | S, sale reported on Form 4 | 12,941 | $325.6K | 2026-04-24 | SEC |
CYTH
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1734779) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
